Search - tctmd.com

Displaying 1 - 20 of 80

Sort: Relevancy | Date

News Daily News

FAME 2 at 10 Years: Less Urgent Revascularization With FFR-Guided PCI

Michael O'Riordan

January 26, 2026

News Daily News

Year in Review: DCBs Big in Coronary News, Along With Beta-blockers in STEMI

Yael L. Maxwell

December 29, 2025

$Coronary Sinus Reducer ‘Promising’ for Refractory Angina: Meta-analysis$

News Daily News

Coronary Sinus Reducer ‘Promising’ for Refractory Angina: Meta-analysis

Todd Neale

August 13, 2025

News Conference News EuroPCR 2025

FLAVOUR Confirms Long-term Noninferiority of FFR vs IVUS to Guide PCI

Yael L. Maxwell

May 30, 2025

News Conference News EuroPCR 2025

Early Coronary Function Testing Improves Quality of Life in ANOCA

Yael L. Maxwell

May 28, 2025

News Conference News EuroPCR 2025

Complete Revascularization in STEMI Still Superior at 10 Years: DANAMI-3-PRIMULTI

Michael O'Riordan

May 20, 2025

News Conference News SCAI 2025

Medicare Analysis Reassures on PCI in Ambulatory Surgery Centers

L.A. McKeown

May 07, 2025

News Conference News CRT 2025

Need for Rethink of Discharge Medications After LAA Closure? EMERGE

L.A. McKeown

March 12, 2025

News Daily News

Deferred Revascularization Safer When Guided by FFR vs QFR: FAVOR III Europe

Caitlin E. Cox

January 09, 2025

News Conference News TCT 2024

QFR No Match for FFR in Guiding Revascularizations: FAVOR III Europe

Caitlin E. Cox

October 30, 2024

News Conference News ESC 2024

NOTION-3: PCI Before TAVI Lowers MACE Risks in Patients With Significant CAD

Michael O'Riordan

September 01, 2024

News Daily News

With ANOCA, Better to Test Coronary Function in Multiple Vessels

Caitlin E. Cox

May 29, 2024

News Conference News EuroPCR 2024

FFR-Derived Metric Can Identify Focal CAD Best Suited to PCI

Caitlin E. Cox

May 20, 2024

News Conference News EuroPCR 2024

PCI for Multivessel Disease More Cost-effective Than CABG at 3 Years: FAME 3

Yael L. Maxwell

May 17, 2024

News Conference News EuroPCR 2024

ORBITA-2: Angina Phenotype Strongly Predicts PCI Response

Caitlin E. Cox

May 15, 2024

News Conference News ACC 2024

PREVENT Supports Early PCI for Vulnerable Plaque, With Reductions in MACE

L.A. McKeown

April 08, 2024

News Daily News

Deferred PCI Equally Safe When Decision-making’s Based on IVUS vs FFR

Caitlin E. Cox

December 07, 2023

News Conference News AHA 2023

Placebo-Controlled ORBITA-2 Shows PCI Eases Symptoms in Stable Angina

Michael O'Riordan

November 11, 2023

News Daily News

Angiogram-Derived Functional Tests Pre-TAVI: Simpler, Yes, but Warranted?

Michael O'Riordan

September 21, 2023

News Daily News

High-risk Plaques in Nonculprit Lesions Tied to Worse Post-MI Outcomes

Caitlin E. Cox

September 18, 2023

Advertisement

FAME 2 at 10 Years: Less Urgent Revascularization With FFR-Guided PCI

Year in Review: DCBs Big in Coronary News, Along With Beta-blockers in STEMI

Coronary Sinus Reducer ‘Promising’ for Refractory Angina: Meta-analysis

FLAVOUR Confirms Long-term Noninferiority of FFR vs IVUS to Guide PCI

Early Coronary Function Testing Improves Quality of Life in ANOCA

Complete Revascularization in STEMI Still Superior at 10 Years: DANAMI-3-PRIMULTI

Medicare Analysis Reassures on PCI in Ambulatory Surgery Centers

Need for Rethink of Discharge Medications After LAA Closure? EMERGE

Deferred Revascularization Safer When Guided by FFR vs QFR: FAVOR III Europe

QFR No Match for FFR in Guiding Revascularizations: FAVOR III Europe

NOTION-3: PCI Before TAVI Lowers MACE Risks in Patients With Significant CAD

With ANOCA, Better to Test Coronary Function in Multiple Vessels

FFR-Derived Metric Can Identify Focal CAD Best Suited to PCI

PCI for Multivessel Disease More Cost-effective Than CABG at 3 Years: FAME 3

ORBITA-2: Angina Phenotype Strongly Predicts PCI Response

PREVENT Supports Early PCI for Vulnerable Plaque, With Reductions in MACE

Deferred PCI Equally Safe When Decision-making’s Based on IVUS vs FFR

Placebo-Controlled ORBITA-2 Shows PCI Eases Symptoms in Stable Angina

Angiogram-Derived Functional Tests Pre-TAVI: Simpler, Yes, but Warranted?

High-risk Plaques in Nonculprit Lesions Tied to Worse Post-MI Outcomes

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content